https://doi.org/10.55788/d66cbf1d
Hormonal transition periods are typically viewed as periods of increased risk for women to develop symptoms of depression. Sex hormone fluctuations and adaptive serotonin changes in late pregnancy both appear to be related to mental health across the peripartum, new findings suggest.
Women have an increased risk of depression compared with men, most prominently during the reproductive years, which suggests a role for hormones in (mal)adaptations. In line with this, it has been found that the use of hormonal contraception, especially among adolescents, is associated with subsequent use of antidepressants and a first diagnosis of depression [1,2]. Recently, it was also shown that healthy women who use oral contraceptives have markedly lower brain 5-HT4 serotonin receptor binding relative to non-users, which constitutes a plausible molecular link between oral contraceptive use and an increased risk of depressive episodes [3]. Dr Vibe Frokjaer (Copenhagen University Hospital, Denmark) presented results from a study that further explored the involvement of serotonin signalling in the emergence of depressive symptoms postpartum and during other sex-hormone transitions [4].
The researchers analysed cerebrospinal fluid of 100 new mothers for central markers of serotonin turn-over (i.e. the metabolite of serotonin, 5-HIAA). They found that higher levels of postpartum mental distress symptoms were positively associated with high antepartum 5-HIAA levels (P=0.06) and negatively associated with a large decrease in oestradiol concentrations (P=0.007). In addition, high antepartum 5-HIAA levels were positively associated with anxiety scores antepartum (P=0.02) [5].
“Adaptive serotonergic changes in late pregnancy appear to be related to mental health across the peripartum and may be important for brain plasticity across the peripartum,” concluded Dr Frokjaer.
- Skovlund CW, et al. JAMA Psychiatry. 2016;73:1154–1162.
- De Wit AE, et al. JAMA Psychiatry. 2020;77:52–59.
- Larsen SV, et al. Acta Psychiatr Scand. 2020;142:294–306.
- Frokjaer VG, et al. Imaging serotonergic resilience: from preclinical gonadotropin challenges to oral hormonal contraceptive use and postpartum hormone changes. Abstract S02.02, ECNP Congress 2022, 15–18 October, Vienna, Austria,.
- Borgsted C, et al. Acta Psychiatr Scand. 2022;146:357–369.
Copyright ©2022 Medicom Medical Publishers
Posted on
« Child loss induces short- and long-term neurobiological changes Next Article
Antidepressant properties of psilocybin might be related to changes in sleep »
Table of Contents: ECNP 2022
Featured articles
Letter from the Editor
New Medications
Zuranolone shows rapid-acting efficacy in postpartum depression
Probiotics could reduce perceived stress
KarXT is effective in schizophrenic patients experiencing acute psychosis
Low-dose ulipristal acetate is an effective treatment for PMDD
New Findings
Endogenous oxytocin release helps the mind to deal with pain
Nitric oxide synthase genetic variant is a risk factor for suicidal behaviour
Early-life gut microbiota depletion changes brain morphology and behaviour
Digital Technology
Treating intrusive memories after trauma in healthcare workers using Tetris
VR exposure as effective as in vivo exposure for phobia
Efficacy of smartphone-based treatment of bipolar disorders not (yet) validated
Psilocybin
Mode of action of psilocybin
Fast and sustained effect of 2 administrations of psilocybin on depression
Antidepressant properties of psilocybin might be related to changes in sleep
Peripartum Neurobiology
Both sex hormones and serotonin play a role in peripartum mental health
Child loss induces short- and long-term neurobiological changes
Reproductive state matters when looking at the female brain and drug treatment effects
Miscellaneous
Different brain responses to fat and/or sugar
Diabetes not related to abnormal biomarkers of Alzheimer’s disease
Oxytocin treatment induces long-lasting neurobiological adaptations in autism
Related Articles
Sublingual dexmedetomidine can curb agitation in bipolar disorder

Letter from the Editor
© 2023 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy